Drug
Samidorphan Olanzapine
Samidorphan Olanzapine: highest development phase Phase 2, developed by Alkermes. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| Samidorphan + olanzapine (ALKS 3831) NCT02161718 | Phase 2 | Schizophrenia |
Latest
No recent events.
Follow Samidorphan Olanzapine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.